...The Woodlands, Texas Business: Autoimmune, Gene/Cell therapy Appointed: Lorin Randall, former SVP and CFO of Eximias Pharmaceutical Corp. WIR...

...Business: Cancer Hired: Gerard Kennealey as SVP of clinical development, formerly SVP and CMO at Eximias Pharmaceutical Corp. WIR...

...YM completed its previously announced acquisition of Eximias for US$29 million in stock (see BioCentury, April...
...at US$5.75, which was YMI's close on May 8, the day before the deal completed. Eximias Pharmaceutical Corp....

...YM will acquire Eximias in a stock and cash deal expected to close in early May...
...but did say that Eximias shareholders will receive at least $25 million in YM stock. Eximias...
...cash, will be renamed YM BioSciences USA Inc. and will serve as YM's U.S. headquarters. Eximias...

...YM (TSX:YM; YMI) said that it will acquire fellow cancer company Eximias (Berwyn, Penn.) in a...
...but did say that Eximias shareholders will receive at least $25 million in YM stock. Eximias...
...will be renamed YM BioSciences USA Inc. and serve as YM's U.S. headquarters. Last August, Eximias'...

...Acorda Therapeutics Inc. (ACOR), Hawthorne, N.Y. Business: Neurology Appointed: Lorin Randall, SVP and CFO at Eximias Pharmaceutical Corp. WIR...

...this indication, was licensed from Agouron Pharmaceuticals Inc. (La Jolla, Calif.), a subsidiary of PFE. Eximias Pharmaceutical Corp....

...Hypertension Submit MAA 3Q05 Epix/Schering Vasovist (MS-325) Cardiovascular imaging FDA response to NDA in November Eximias/Pfizer...